Skip to main content
  • Saved

Trial of Galcanezumab in Prevention of Episodic Cluster Headache

Source : https://www.nejm.org/doi/full/10.1056/NEJMoa1813440

AbstractBACKGROUNDEpisodic cluster headache is a disabling neurologic disorder that is characterized by daily headache attacks that occur over periods of weeks or months. Galcanezumab, a humanized monoclonal antibody to calcitonin gene–related peptide, may be a preventive treatment for cluster headache.

Sign In or Register Today to Access This Content